Cardiovascular Disease Biomarker Assay Kits Using Luminex® Technology

Request Information

---

Related Resources: Analyte Quarterly | Application Notes | Posters

---

Measure cardiovascular biomarkers – such as fibrinogen, CRP, and myeloperoxidase – with MILLIPLEX® MAP multiplexed assay kits. Cardiovascular disease (CVD), particularly atherosclerotic vascular disease, is a leading cause of global mortality, accounting for 30% of all deaths annually (WHO). Inflammation pathways play a vital role in the initiation, maintenance and progression of vascular disease, and there is a strong correlation between inflammation biomarkers (such as acute phase proteins) and prognosis in coronary artery disease.

Bring your cardiovascular disease biomarkers to life with MILLIPLEX® MAP Multiplex CVD Assays

For a complete picture of CVD, you need to analyze data for multiple proteins from multiple systems. Trust Merck’s growing MILLIPLEX® MAP portfolio of multiplexed CVD biomarker assays for precise lot-to-lot consistency.

Based on Luminex xMAP® technology, our analytically validated assay kits provide:
Some examples of the cardiovascular disease biomarker assay analytes in our portfolio are listed below.

Cardiovascular Disease Biomarkers*:

Biomarkers that may indicate a higher risk for heart disease include:

Troponin I	Troponin T	BNP (B-type natriuretic peptide)
NT-proBNP	sICAM-1	Myeloperoxidase

*only selected analytes listed

Acute Phase Proteins*:

Acute phase proteins are produced in the liver in response to proinflammatory cytokines. The serum concentrations of these proteins change significantly in response to inflammation, and low-grade inflammation has been correlated with cardiovascular disease.

CRP	Fibrinogen	Serum Amyloid P
Von Willebrand Factor (vWF)	α-2-Macroglobulin	L-Selectin

*only selected analytes listed

Apolipoproteins

These proteins bind to and transport lipids through the bloodstream; their levels may correlate with risk of coronary heart disease.

Apo AI	Apo AII	Apo B
Apo CII	Apo CIII	Apo E

Cardiovascular heart disease may be coincident with metabolic syndrome. Simultaneously measure biomarkers of both disease states by choosing among MILLIPLEX® MAP metabolism biomarker assay kits.

Numerous studies have demonstrated an association between the inflammation pathway and cardiovascular risk factors. Enrich your CVD studies by adding MILLIPLEX® MAP inflammation assay panels to your experiments.

---

Download the Analyte Quarterly brochure for a complete, updated list of assays.

---

Find and Price Your Favorite Analytes & Kits —
Two Tools to Make Ordering Faster and Easier!